Eicosanoid-Regulated Myeloid ENaC and Isolevuglandin Formation in Human Salt-Sensitive Hypertension

Author:

Ertuglu Lale A.1ORCID,Pitzer Mutchler Ashley2ORCID,Jamison S.23,Laffer Cheryl L.2ORCID,Elijovich Fernando2ORCID,Saleem Mohammad2ORCID,Blackwell Daniel J.2ORCID,Kryshtal Dmytro O.2ORCID,Egly Christian L.2,Sahinoz Melis4,Sheng Quanhu5ORCID,Wanjalla Celestine N.6ORCID,Pakala Suman6,Yu Justin7,Gutierrez Orlando M.8ORCID,Kleyman Thomas R.910ORCID,Knollmann Björn C.2ORCID,Ikizler T. Alp1ORCID,Kirabo Annet29111210ORCID

Affiliation:

1. Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. (L.A.E., T.A.I.)

2. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. (A.P.M., S.J., C.L.L., F.E., M.S., D.J.B., D.O.K., C.L.E., B.C.K., A.K.)

3. Meharry Medical College Nashville, TN (S.J.).

4. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. (M.S.)

5. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN. (Q.S.)

6. Division of Infectious Diseases, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN. (C.N.W., S.P.)

7. Department of Biological Sciences, Vanderbilt University, Nashville, TN (J.Y.).

8. Division of Nephrology, Department of Medicine, University of Alabama at Birmingham (O.M.G.).

9. Vanderbilt Center for Immunobiology (VCI) (T.R.K., A.K.).

10. Departments of Medicine, Cell Biology, Pharmacology, and Chemical Biology, University of Pittsburgh, PA (T.R.K., A.K.).

11. Vanderbilt Institute for Infection, Immunology, and Inflammation (VI4) (A.K.).

12. Vanderbilt Institute for Global Health (VIGH) (A.K.).

Abstract

Background: The mechanisms by which salt increases blood pressure in people with salt sensitivity remain unclear. Our previous studies found that high sodium enters antigen-presenting cells (APCs) via the epithelial sodium channel and leads to the production of isolevuglandins and hypertension. In the current mechanistic clinical study, we hypothesized that epithelial sodium channel–dependent isolevuglandin-adduct formation in APCs is regulated by epoxyeicosatrienoic acids (EETs) and leads to salt-sensitive hypertension in humans. Methods: Salt sensitivity was assessed in 19 hypertensive subjects using an inpatient salt loading and depletion protocol. Isolevuglandin-adduct accumulation in APCs was analyzed using flow cytometry. Gene expression in APCs was analyzed using cellular indexing of transcriptomes and epitopes by sequencing analysis of blood mononuclear cells. Plasma and urine EETs were measured using liquid chromatography–mass spectrometry. Results: Baseline isolevuglandin + APCs correlated with higher salt-sensitivity index. Isolevuglandin + APCs significantly decreased from salt loading to depletion with an increasing salt-sensitivity index. We observed that human APCs express the epithelial sodium channel δ subunit, SGK1 (salt-sensing kinase serum/glucocorticoid kinase 1), and cytochrome P450 2S1. We found a direct correlation between baseline urinary EET 14-15 and salt-sensitivity index, whereas changes in urinary EET 14-15 negatively correlated with isolevuglandin + monocytes from salt loading to depletion. Coincubation with EET 14-15 inhibited high-salt–induced increase in isolevuglandin + APC isolevuglandins. Conclusions: Isolevuglandin formation in APCs responds to acute changes in salt intake in salt-sensitive but not salt-resistant people with hypertension, and this may be regulated by renal EET 14-15. Baseline levels of isolevuglandin + APCs or urinary EET 14-15 may provide diagnostic tools for salt sensitivity without a protocol of salt loading.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3